DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹139 Cr | ₹-936 Cr | ₹-70 Cr | ₹1,275 Cr | ₹-24 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DR REDDYS LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹139 Cr |
Mar2023 | ₹-936 Cr |
Mar2022 | ₹-70 Cr |
Mar2021 | ₹1,275 Cr |
Mar2020 | ₹-24 Cr |
How is Net Cash Inflow / Outflow of DR REDDYS LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹139 Cr | Positive | |
Mar2023 | ₹-936 Cr | Negative | |
Mar2022 | ₹-70 Cr | Negative | |
Mar2021 | ₹1,275 Cr | Positive | |
Mar2020 | ₹-24 Cr | - |
Compare Net Cash Inflow / Outflow of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹110,095.6 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,519.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,903.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
CIPLA | ₹121,669.0 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,605.0 Cr | 1.4% | 1.3% | 17% | Stock Analytics | |
MANKIND PHARMA | ₹97,239.7 Cr | 0.2% | -2.4% | 12.5% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 5.7% |
14.1% |
15.2% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses